Literature DB >> 9614954

Acute radiation reaction and local control in breast cancer patients treated with postmastectomy radiotherapy.

T Kuhnt1, C Richter, H Enke, J Dunst.   

Abstract

BACKGROUND: We have investigated the variation of acute radiation reactions in medium-risk patients with postmastectomy radiotherapy with regard to a possible correlation between radiation reaction of normal tissues and local tumor control.
MATERIAL AND METHODS: From 1985 through 1991, a total number of 194 patients received postmastectomy radiotherapy for breast cancer pT1-2pN0-2M0 at the University of Halle-Wittenberg. The lymphatics were irradiated by an anterior 9-MV photon field and the chest wall by an individually shaped anterior field with 9-MV electrons. Both fields received single doses of 2 Gy 5 times weekly up to a total dose of 44 Gy to the chest wall and 50 Gy to the lymphatics. All patients were routinely evaluated once weekly during radiotherapy for acute side effects by one examiner. Skin erythema was classified as mild, moderate or severe, esophagitis as being present in form of dysphagia or not and pneumonitis, if present, as asymptomatic (visible only on repeated chest X-rays) or clinically symptomatic. A differential blood count was also carried out once weekly. For this analysis, the records of all patients were retrospectively reviewed. The median follow-up at the time of analysis was 4.2 years.
RESULTS: Of the patients, 98 (51%) had a mild, 53 (27%) moderate and 43 (22%) a severe erythema. Furthermore, 38 patients (20%) had signs of esophagitis, 13 (7%) had asymptomatic and 26 (13%) symptomatic pneumonitis. Patients with severe erythema or erythema plus esophagitis and pneumonitis had a more pronounced decrease in lymphocyte count during treatment than patients with mild erythema: the lymphocyte nadir was 0.14 vs 0.73 Gpt/l in patients with severe vs mild erythema, and 0.36 vs 0.69 Gpt/l in patients with erythema plus esophagitis plus pneumonitis vs patients with erythema only, p < 0.05. Of the patients, 44 (22%) developed chronic side effects, mostly arm edema. There was no correlation between acute and late effects. An overall number of seven local recurrences (3.6%) occurred. The risk of developing a local recurrence within 5 years after treatment was 0% in patients with severe erythema or erythema plus esophagitis/pneumonitis vs 7% in patients with mild erythema only; this difference was marginally significant, p = 0.055.
CONCLUSIONS: This analysis showed a trend towards better local control in patients with severe acute radiation reaction of normal tissue. The data support a recent publication by Dahl and coworkers showing a linkage between acute radiation reaction of normal tissue and tumor response in patients with preoperative radiotherapy for rectal cancer. The correlation between acute normal tissue reaction and local control might be explained by interindividual variations in the intrinsic, genetically determined radiosensitivity. However, local factors might also be involved, e.g. induction of a cytokin cascade in cases of acute reactions in normal tissues.

Entities:  

Mesh:

Year:  1998        PMID: 9614954     DOI: 10.1007/bf03038718

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  20 in total

1.  Prediction of normal-tissue tolerance to radiotherapy from in-vitro cellular radiation sensitivity.

Authors:  N G Burnet; J Nyman; I Turesson; R Wurm; J R Yarnold; J H Peacock
Journal:  Lancet       Date:  1992-06-27       Impact factor: 79.321

2.  Comparison between normal tissue reactions and local tumor control in head and neck cancer patients treated by definitive radiotherapy.

Authors:  F B Geara; L J Peters; K K Ang; A S Garden; S L Tucker; L B Levy; B W Brown
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-06-01       Impact factor: 7.038

3.  The relationship between early and late gastrointestinal complications of radiation therapy for carcinoma of the cervix.

Authors:  R G Bourne; J H Kearsley; W D Grove; S J Roberts
Journal:  Int J Radiat Oncol Biol Phys       Date:  1983-10       Impact factor: 7.038

4.  Evidence for individual differences in the radiosensitivity of human skin.

Authors:  S L Tucker; I Turesson; H D Thames
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

5.  Clinical correlations between late normal tissue endpoints after radiotherapy: implications for predictive assays of radiosensitivity.

Authors:  S M Bentzen; M Overgaard; J Overgaard
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

6.  Intrinsic radiosensitivity of normal human fibroblasts and lymphocytes after high- and low-dose-rate irradiation.

Authors:  F B Geara; L J Peters; K K Ang; J L Wike; S S Sivon; R Guttenberger; D L Callender; E P Malaise; W A Brock
Journal:  Cancer Res       Date:  1992-11-15       Impact factor: 12.701

7.  The progression rate of late radiation effects in normal tissue and its impact on dose-response relationships.

Authors:  I Turesson
Journal:  Radiother Oncol       Date:  1989-07       Impact factor: 6.280

8.  Do acute side-effects during radiotherapy predict tumour response in rectal carcinoma?

Authors:  O Dahl; A Horn; O Mella
Journal:  Acta Oncol       Date:  1994       Impact factor: 4.089

9.  Breast and other cancers in families with ataxia-telangiectasia.

Authors:  M Swift; P J Reitnauer; D Morrell; C L Chase
Journal:  N Engl J Med       Date:  1987-05-21       Impact factor: 91.245

10.  Fibroblast radiosensitivity versus acute and late normal skin responses in patients treated for breast cancer.

Authors:  W A Brock; S L Tucker; F B Geara; I Turesson; J Wike; J Nyman; L J Peters
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-07-30       Impact factor: 7.038

View more
  11 in total

1.  High-grade acute organ toxicity as positive prognostic factor in primary radio(chemo)therapy for locally advanced, inoperable head and neck cancer.

Authors:  Hendrik Andreas Wolff; Jan Bosch; Klaus Jung; Tobias Overbeck; Steffen Hennies; Christoph Matthias; Clemens F Hess; Ralph M Roedel; Hans Christiansen
Journal:  Strahlenther Onkol       Date:  2010-04-26       Impact factor: 3.621

2.  Unintended irradiation of internal mammary chain - Is that enough?

Authors:  Lucas Gomes Sapienza; Michael Jenwei Chen; Maria José Leite Gomes; David B Mansur
Journal:  Rep Pract Oncol Radiother       Date:  2015-08-11

Review 3.  Imaging radiation-induced normal tissue injury.

Authors:  Mike E Robbins; Judy K Brunso-Bechtold; Ann M Peiffer; Christina I Tsien; Janet E Bailey; Lawrence B Marks
Journal:  Radiat Res       Date:  2012-02-21       Impact factor: 2.841

4.  Unplanned irradiation of internal mammary lymph nodes in breast cancer.

Authors:  Gul Kanyilmaz; Meryem Aktan; Mehmet Koc; Hikmettin Demir; Lütfi Saltuk Demir
Journal:  Radiol Med       Date:  2017-03-03       Impact factor: 3.469

5.  High-grade acute organ toxicity and p16(INK4A) expression as positive prognostic factors in primary radio(chemo)therapy for patients with head and neck squamous cell carcinoma.

Authors:  Narges Tehrany; Julia Kitz; Margret Rave-Fränk; Stephan Lorenzen; Li Li; Stefan Küffer; Clemens F Hess; Peter Burfeind; Holger M Reichardt; Martin Canis; Tim Beissbarth; Hendrik A Wolff
Journal:  Strahlenther Onkol       Date:  2015-01-10       Impact factor: 3.621

6.  Chromosomal in-vitro radiosensitivity of lymphocytes in radiotherapy patients and AT-homozygotes.

Authors:  J Dunst; S Neubauer; A Becker; E Gebhart
Journal:  Strahlenther Onkol       Date:  1998-10       Impact factor: 3.621

Review 7.  Enhanced radiation sensitivity and radiation recall dermatitis (RRD) after hypericin therapy -- case report and review of literature.

Authors:  Kurt Putnik; Peter Stadler; Christof Schäfer; Oliver Koelbl
Journal:  Radiat Oncol       Date:  2006-09-01       Impact factor: 3.481

8.  Radiation testing of the AeroForm CO2-based breast tissue expander implant.

Authors:  James L Rembert; Roxana Heitz; Adam Hoffman
Journal:  Radiat Oncol       Date:  2013-10-11       Impact factor: 3.481

9.  Concurrent chemotherapy for T4 classification nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy.

Authors:  Cai-neng Cao; Jing-wei Luo; Li Gao; Jun-lin Yi; Xiao-dong Huang; Kai Wang; Shi-ping Zhang; Yuan Qu; Su-yan Li; Jian-ping Xiao; Zhong Zhang; Guo-zhen Xu
Journal:  PLoS One       Date:  2015-03-06       Impact factor: 3.240

10.  Occurrence of pneumonitis following radiotherapy of breast cancer - A prospective study.

Authors:  Danijela Vasiljevic; Christoph Arnold; David Neuman; Katharina Fink; Marina Popovscaia; Irma Kvitsaridze; Meinhard Nevinny-Stickel; Markus Glatzer; Peter Lukas; Thomas Seppi
Journal:  Strahlenther Onkol       Date:  2018-02-15       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.